Invenomic Capital Management’s BorgWarner BWA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-118,459
Closed -$4.2M – 145
2022
Q4
$4.2M Buy
118,459
+52,714
+80% +$1.79M 0.28% 96
2022
Q3
$1.82M Buy
+65,745
New +$2.12M 0.16% 124
2022
Q2
– Sell
-64,353
Closed -$1.8M – 152
2022
Q1
$1.8M Buy
64,353
+34,995
+119% +$1.31M 0.19% 105
2021
Q4
$1.17M Buy
29,358
+9,027
+44% +$363K 0.25% 104
2021
Q3
$773K Buy
20,331
+2,136
+12% +$84.9K 0.25% 94
2021
Q2
$777K Sell
18,195
-3,208
-15% -$141K 0.19% 90
2021
Q1
$874K Buy
21,403
+14,198
+197% +$553K 0.19% 86
2020
Q4
$245K Sell
7,205
-2,097
-23% -$71.1K 0.06% 122
2020
Q3
$317K Sell
9,302
-991
-10% -$34.1K 0.17% 113
2020
Q2
$319K Buy
+10,293
New +$271K 0.24% 109

Other funds holding BWA

Invenomic Capital Management's BWA Position: Q1 2023 in Review

Invenomic Capital Management sold out of BorgWarner (BWA) in Q1 2023, closing a stake of 118,459 shares — an estimated $4.2M sold.

Invenomic Capital Management first reported a position in BWA in Q2 2020 and held it in 10 quarters. The position peaked at $4.2M in Q4 2022. 707 funds tracked by Wall St. Rank hold BWA as of Q1 2023.

  • Invenomic Capital Management reported no remaining BorgWarner position as of Q1 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 118,459 BorgWarner shares in Q1 2023, an estimated $4.2M.
  • Invenomic Capital Management first reported a position in BorgWarner in Q2 2020 and held it in 10 quarters.
  • Invenomic Capital Management's BorgWarner position peaked at $4.2M in Q4 2022.
  • 707 funds tracked by Wall St. Rank held BorgWarner as of Q1 2023.

Based on Invenomic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.